clinigen healthcare limited
clinigen healthcare limited Company Information
Company Number
06252720
Next Accounts
Mar 2025
Shareholders
clinigen holdings limited
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
pitcairn house crown square, centrum 100, burton on trent, staffordshire, DE14 2WW
Website
www.clinigengroup.comclinigen healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of CLINIGEN HEALTHCARE LIMITED at £219.9m based on a Turnover of £277m and 0.79x industry multiple (adjusted for size and gross margin).
clinigen healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of CLINIGEN HEALTHCARE LIMITED at £0 based on an EBITDA of £-10.4m and a 8.02x industry multiple (adjusted for size and gross margin).
clinigen healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of CLINIGEN HEALTHCARE LIMITED at £410.1m based on Net Assets of £213.9m and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Clinigen Healthcare Limited Overview
Clinigen Healthcare Limited is a live company located in burton on trent, DE14 2WW with a Companies House number of 06252720. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in May 2007, it's largest shareholder is clinigen holdings limited with a 100% stake. Clinigen Healthcare Limited is a established, mega sized company, Pomanda has estimated its turnover at £277m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Clinigen Healthcare Limited Health Check
Pomanda's financial health check has awarded Clinigen Healthcare Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
5 Weak
Size
annual sales of £277m, make it larger than the average company (£24.2m)
£277m - Clinigen Healthcare Limited
£24.2m - Industry AVG
Growth
3 year (CAGR) sales growth of -3%, show it is growing at a slower rate (5.5%)
-3% - Clinigen Healthcare Limited
5.5% - Industry AVG
Production
with a gross margin of 17.6%, this company has a higher cost of product (27.1%)
17.6% - Clinigen Healthcare Limited
27.1% - Industry AVG
Profitability
an operating margin of -5.1% make it less profitable than the average company (4.1%)
-5.1% - Clinigen Healthcare Limited
4.1% - Industry AVG
Employees
with 295 employees, this is above the industry average (34)
295 - Clinigen Healthcare Limited
34 - Industry AVG
Pay Structure
on an average salary of £71.8k, the company has an equivalent pay structure (£76.8k)
£71.8k - Clinigen Healthcare Limited
£76.8k - Industry AVG
Efficiency
resulting in sales per employee of £939.1k, this is more efficient (£672.9k)
£939.1k - Clinigen Healthcare Limited
£672.9k - Industry AVG
Debtor Days
it gets paid by customers after 43 days, this is earlier than average (58 days)
43 days - Clinigen Healthcare Limited
58 days - Industry AVG
Creditor Days
its suppliers are paid after 26 days, this is quicker than average (33 days)
26 days - Clinigen Healthcare Limited
33 days - Industry AVG
Stock Days
it holds stock equivalent to 33 days, this is less than average (57 days)
33 days - Clinigen Healthcare Limited
57 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (10 weeks)
1 weeks - Clinigen Healthcare Limited
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 59%, this is a similar level of debt than the average (58.4%)
59% - Clinigen Healthcare Limited
58.4% - Industry AVG
CLINIGEN HEALTHCARE LIMITED financials
Clinigen Healthcare Limited's latest turnover from June 2023 is £277 million and the company has net assets of £213.9 million. According to their latest financial statements, Clinigen Healthcare Limited has 295 employees and maintains cash reserves of £9.2 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 277,022,000 | 317,472,000 | 288,202,000 | 301,887,000 | 247,802,000 | 207,955,000 | 86,605,000 | 54,837,000 | 47,967,000 | 43,017,000 | 34,827,000 | 23,335,000 | 11,655,000 | 5,078,376 |
| Other Income Or Grants | -486,000 | |||||||||||||
| Cost Of Sales | 228,333,000 | 259,048,000 | 223,799,000 | 190,624,000 | 167,338,000 | 141,847,000 | 38,759,000 | 20,774,000 | 16,382,000 | 15,567,000 | 10,814,000 | 4,560,000 | 2,285,000 | 2,245,555 |
| Gross Profit | 48,689,000 | 57,938,000 | 64,403,000 | 111,263,000 | 80,464,000 | 66,108,000 | 47,846,000 | 34,063,000 | 31,585,000 | 27,450,000 | 24,013,000 | 18,775,000 | 9,370,000 | 2,832,821 |
| Admin Expenses | 62,676,000 | 48,532,000 | 20,920,000 | 53,124,000 | 18,837,000 | 22,210,000 | 17,378,000 | 13,749,000 | 16,476,000 | 15,479,000 | 14,539,000 | 8,389,000 | 5,686,000 | 2,595,226 |
| Operating Profit | -13,987,000 | 9,406,000 | 43,483,000 | 58,139,000 | 61,627,000 | 43,898,000 | 30,468,000 | 20,314,000 | 15,109,000 | 11,971,000 | 9,474,000 | 10,386,000 | 3,684,000 | 237,595 |
| Interest Payable | 2,776,000 | 249,000 | 8,241,000 | 318,000 | 52,000 | 556,000 | 1,000 | 6,000 | 71,000 | 18,692 | ||||
| Interest Receivable | 1,940,000 | 4,025,000 | 811,000 | 1,991,000 | 2,427,000 | 25,000 | 15,000 | 7,414 | ||||||
| Pre-Tax Profit | -14,823,000 | 13,182,000 | 36,053,000 | 59,812,000 | 64,002,000 | 43,342,000 | 30,467,000 | 20,314,000 | 15,134,000 | 11,971,000 | 9,489,000 | 10,380,000 | 3,613,000 | 226,317 |
| Tax | 4,972,000 | 143,000 | -3,999,000 | -9,192,000 | -6,815,000 | -7,622,000 | -5,565,000 | -2,539,000 | -1,342,000 | -2,730,000 | 3,126,000 | -2,644,000 | -1,022,000 | -63,535 |
| Profit After Tax | -9,851,000 | 13,325,000 | 32,054,000 | 50,620,000 | 57,187,000 | 35,720,000 | 24,902,000 | 17,775,000 | 13,792,000 | 9,241,000 | 12,615,000 | 7,736,000 | 2,591,000 | 162,782 |
| Dividends Paid | 26,000,000 | 11,087,000 | 11,000,000 | 6,000,000 | ||||||||||
| Retained Profit | -9,851,000 | 13,325,000 | 32,054,000 | 50,620,000 | 57,187,000 | 35,720,000 | -1,098,000 | 6,688,000 | 13,792,000 | 9,241,000 | 1,615,000 | 1,736,000 | 2,591,000 | 162,782 |
| Employee Costs | 21,186,000 | 21,456,000 | 13,785,000 | 16,223,000 | 10,383,000 | 2,269,000 | 2,127,000 | 2,636,000 | 2,456,000 | 2,210,000 | 1,878,000 | 1,051,000 | 1,454,000 | |
| Number Of Employees | 295 | 323 | 294 | 271 | 180 | 32 | 19 | 40 | 40 | 36 | 25 | 26 | 13 | |
| EBITDA* | -10,397,000 | 14,680,000 | 46,614,000 | 60,710,000 | 62,375,000 | 44,301,000 | 31,460,000 | 21,783,000 | 16,434,000 | 13,411,000 | 10,798,000 | 11,551,000 | 4,768,000 | 700,505 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,129,000 | 941,000 | 3,684,000 | 4,161,000 | 1,162,000 | 291,000 | 191,000 | 30,000 | 39,735 | |||||
| Intangible Assets | 9,654,000 | 11,982,000 | 10,582,000 | 8,953,000 | 3,151,000 | 1,287,000 | 595,000 | 1,418,000 | 2,881,000 | 3,952,000 | 5,276,000 | 6,600,000 | 5,935,000 | 6,998,113 |
| Investments & Other | 37,802,000 | 34,158,000 | 33,868,000 | 17,865,000 | 17,865,000 | 44,691,000 | 1,000 | |||||||
| Debtors (Due After 1 year) | 359,000 | 446,000 | 690,000 | |||||||||||
| Total Fixed Assets | 48,585,000 | 47,081,000 | 48,493,000 | 31,425,000 | 22,868,000 | 45,978,000 | 596,000 | 1,418,000 | 2,881,000 | 4,243,000 | 5,467,000 | 6,600,000 | 5,965,000 | 7,037,848 |
| Stock & work in progress | 20,923,000 | 32,743,000 | 29,291,000 | 16,823,000 | 17,215,000 | 7,311,000 | 7,058,000 | 6,122,000 | 4,090,000 | 2,302,000 | 1,523,000 | 1,733,000 | 359,000 | 17,666 |
| Trade Debtors | 32,889,000 | 47,939,000 | 53,093,000 | 53,605,000 | 34,982,000 | 46,042,000 | 14,756,000 | 9,451,000 | 9,839,000 | 7,323,000 | 4,775,000 | 2,608,000 | 1,874,000 | 252,968 |
| Group Debtors | 396,522,000 | 322,232,000 | 273,161,000 | 215,008,000 | 189,716,000 | 114,245,000 | 27,607,000 | 21,893,000 | 9,935,000 | 159,000 | 17,000 | 999 | ||
| Misc Debtors | 13,585,000 | 17,720,000 | 28,413,000 | 19,009,000 | 26,378,000 | 11,501,000 | 5,220,000 | 3,038,000 | 2,420,000 | 2,959,000 | 4,141,000 | 602,000 | 611,000 | 555,578 |
| Cash | 9,173,000 | 53,963,000 | 30,724,000 | 41,017,000 | 22,254,000 | 4,947,000 | 5,233,000 | 3,247,000 | 6,159,000 | 4,428,000 | 3,635,000 | 2,434,000 | 2,891,000 | 1,508,720 |
| misc current assets | 48,000 | 246,000 | 37,000 | 61,000 | ||||||||||
| total current assets | 473,140,000 | 474,597,000 | 414,682,000 | 345,708,000 | 290,545,000 | 184,046,000 | 59,911,000 | 43,751,000 | 32,504,000 | 17,171,000 | 14,074,000 | 7,377,000 | 5,752,000 | 2,335,931 |
| total assets | 521,725,000 | 521,678,000 | 463,175,000 | 377,133,000 | 313,413,000 | 230,024,000 | 60,507,000 | 45,169,000 | 35,385,000 | 21,414,000 | 19,541,000 | 13,977,000 | 11,717,000 | 9,373,779 |
| Bank overdraft | ||||||||||||||
| Bank loan | ||||||||||||||
| Trade Creditors | 16,737,000 | 43,218,000 | 33,196,000 | 31,231,000 | 34,695,000 | 39,052,000 | 13,497,000 | 2,251,000 | 2,474,000 | 1,078,000 | 1,521,000 | 1,129,000 | 1,503,000 | 194,102 |
| Group/Directors Accounts | 267,050,000 | 232,065,000 | 182,336,000 | 139,960,000 | 119,644,000 | 100,917,000 | 1,007,000 | 800,000 | 1,105,000 | 717,000 | 8,230,000 | 2,814,000 | 887,601 | |
| other short term finances | 189,000 | 1,000 | 341,000 | 387,000 | 468,000 | |||||||||
| hp & lease commitments | 517,000 | 531,000 | 546,000 | 635,000 | ||||||||||
| other current liabilities | 22,190,000 | 20,268,000 | 34,281,000 | 23,049,000 | 30,977,000 | 19,356,000 | 11,047,000 | 6,064,000 | 2,440,000 | 4,045,000 | 3,457,000 | 5,316,000 | 5,778,000 | 6,936,887 |
| total current liabilities | 306,494,000 | 296,271,000 | 250,360,000 | 195,216,000 | 185,703,000 | 159,793,000 | 25,551,000 | 9,115,000 | 6,019,000 | 5,840,000 | 13,208,000 | 9,259,000 | 7,281,000 | 8,018,590 |
| loans | 659,900 | |||||||||||||
| hp & lease commitments | 1,289,000 | 1,851,000 | 2,396,000 | 2,851,000 | ||||||||||
| Accruals and Deferred Income | ||||||||||||||
| other liabilities | 795,000 | 660,000 | 305,000 | |||||||||||
| provisions | 795,000 | |||||||||||||
| total long term liabilities | 1,289,000 | 1,851,000 | 2,396,000 | 3,646,000 | 1,455,000 | 964,900 | ||||||||
| total liabilities | 307,783,000 | 298,122,000 | 252,756,000 | 198,862,000 | 185,703,000 | 159,793,000 | 25,551,000 | 9,115,000 | 6,019,000 | 5,840,000 | 13,208,000 | 9,259,000 | 8,736,000 | 8,983,490 |
| net assets | 213,942,000 | 223,556,000 | 210,419,000 | 178,271,000 | 127,710,000 | 70,231,000 | 34,956,000 | 36,054,000 | 29,366,000 | 15,574,000 | 6,333,000 | 4,718,000 | 2,981,000 | 390,289 |
| total shareholders funds | 213,942,000 | 223,556,000 | 210,419,000 | 178,271,000 | 127,710,000 | 70,231,000 | 34,956,000 | 36,054,000 | 29,366,000 | 15,574,000 | 6,333,000 | 4,718,000 | 2,981,000 | 390,289 |
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | -13,987,000 | 9,406,000 | 43,483,000 | 58,139,000 | 61,627,000 | 43,898,000 | 30,468,000 | 20,314,000 | 15,109,000 | 11,971,000 | 9,474,000 | 10,386,000 | 3,684,000 | 237,595 |
| Depreciation | 452,000 | 934,000 | 787,000 | 787,000 | 58,000 | 21,000 | 19,992 | |||||||
| Amortisation | 3,138,000 | 4,340,000 | 2,344,000 | 1,784,000 | 748,000 | 403,000 | 992,000 | 1,469,000 | 1,325,000 | 1,382,000 | 1,324,000 | 1,165,000 | 1,063,000 | 442,918 |
| Tax | 4,972,000 | 143,000 | -3,999,000 | -9,192,000 | -6,815,000 | -7,622,000 | -5,565,000 | -2,539,000 | -1,342,000 | -2,730,000 | 3,126,000 | -2,644,000 | -1,022,000 | -63,535 |
| Stock | -11,820,000 | 3,452,000 | 12,468,000 | -392,000 | 9,904,000 | 253,000 | 936,000 | 2,032,000 | 1,788,000 | 779,000 | -210,000 | 1,374,000 | 341,334 | 17,666 |
| Debtors | 55,105,000 | 32,865,000 | 66,958,000 | 36,302,000 | 79,978,000 | 124,205,000 | 13,201,000 | 12,188,000 | 11,753,000 | 1,525,000 | 5,706,000 | 708,000 | 1,692,455 | 809,545 |
| Creditors | -26,481,000 | 10,022,000 | 1,965,000 | -3,464,000 | -4,357,000 | 25,555,000 | 11,246,000 | -223,000 | 1,396,000 | -443,000 | 392,000 | -374,000 | 1,308,898 | 194,102 |
| Accruals and Deferred Income | 1,922,000 | -14,013,000 | 11,232,000 | -7,928,000 | 11,621,000 | 8,309,000 | 4,983,000 | 3,624,000 | -1,605,000 | 588,000 | -1,859,000 | -462,000 | -1,158,887 | 6,936,887 |
| Deferred Taxes & Provisions | -795,000 | 795,000 | ||||||||||||
| Cash flow from operations | -73,269,000 | -25,485,000 | -23,614,000 | 4,216,000 | -27,058,000 | -53,915,000 | 27,987,000 | 8,425,000 | 8,522,000 | 6,961,000 | 5,194,000 | 2,657,222 | 6,940,748 | |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 3,644,000 | 290,000 | 16,003,000 | -26,826,000 | 44,690,000 | 1,000 | ||||||||
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | ||||||||||||||
| Group/Directors Accounts | 34,985,000 | 49,729,000 | 42,376,000 | 20,316,000 | 18,727,000 | 99,910,000 | 207,000 | -305,000 | 388,000 | -7,513,000 | 5,416,000 | 2,814,000 | -887,601 | 887,601 |
| Other Short Term Loans | -189,000 | 188,000 | -340,000 | -46,000 | -81,000 | 468,000 | ||||||||
| Long term loans | -659,900 | 659,900 | ||||||||||||
| Hire Purchase and Lease Commitments | -576,000 | -560,000 | -544,000 | 3,486,000 | ||||||||||
| other long term liabilities | -795,000 | 795,000 | -660,000 | 355,000 | 305,000 | |||||||||
| share issue | ||||||||||||||
| interest | -836,000 | 3,776,000 | -7,430,000 | 1,673,000 | 2,375,000 | -556,000 | -1,000 | 25,000 | 15,000 | -6,000 | -71,000 | -11,278 | ||
| cash flow from financing | 33,621,000 | 52,945,000 | 33,361,000 | 26,165,000 | 21,313,000 | 99,377,000 | 206,000 | -305,000 | 413,000 | -7,513,000 | 5,431,000 | 2,149,000 | -1,263,790 | 2,068,730 |
| cash and cash equivalents | ||||||||||||||
| cash | -44,790,000 | 23,239,000 | -10,293,000 | 18,763,000 | 17,307,000 | -286,000 | 1,986,000 | -2,912,000 | 1,731,000 | 793,000 | 1,201,000 | -457,000 | 1,382,280 | 1,508,720 |
| overdraft | ||||||||||||||
| change in cash | -44,790,000 | 23,239,000 | -10,293,000 | 18,763,000 | 17,307,000 | -286,000 | 1,986,000 | -2,912,000 | 1,731,000 | 793,000 | 1,201,000 | -457,000 | 1,382,280 | 1,508,720 |
clinigen healthcare limited Credit Report and Business Information
Clinigen Healthcare Limited Competitor Analysis
Perform a competitor analysis for clinigen healthcare limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mega companies, companies in DE14 area or any other competitors across 12 key performance metrics.
clinigen healthcare limited Ownership
CLINIGEN HEALTHCARE LIMITED group structure
Clinigen Healthcare Limited has 4 subsidiary companies.
Ultimate parent company
TRILEY HOLDCO LTD
#0139690
2 parents
CLINIGEN HEALTHCARE LIMITED
06252720
4 subsidiaries
clinigen healthcare limited directors
Clinigen Healthcare Limited currently has 2 directors. The longest serving directors include Mr Richard Paling (Aug 2021) and Mr Jerome Charton (Apr 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Richard Paling | United Kingdom | 54 years | Aug 2021 | - | Director |
| Mr Jerome Charton | England | 60 years | Apr 2024 | - | Director |
P&L
June 2023turnover
277m
-13%
operating profit
-14m
-249%
gross margin
17.6%
-3.69%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
213.9m
-0.04%
total assets
521.7m
0%
cash
9.2m
-0.83%
net assets
Total assets minus all liabilities
Similar Companies
clinigen healthcare limited company details
company number
06252720
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
May 2007
age
18
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
June 2023
previous names
N/A
accountant
-
auditor
-
address
pitcairn house crown square, centrum 100, burton on trent, staffordshire, DE14 2WW
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
clinigen healthcare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 8 charges/mortgages relating to clinigen healthcare limited. Currently there are 1 open charges and 7 have been satisfied in the past.
clinigen healthcare limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CLINIGEN HEALTHCARE LIMITED. This can take several minutes, an email will notify you when this has completed.
clinigen healthcare limited Companies House Filings - See Documents
| date | description | view/download |
|---|
